Article Highlight | 30-Jul-2025

Fungal communities in kidney tumors affect cancer treatment success

FAR Publishing Limited

Groundbreaking Discovery: Fungi in Kidney Tumors May Hold Key to Better Cancer Treatment

Scientists have made a surprising discovery about kidney cancer that could revolutionize how doctors predict and improve treatment outcomes. While researchers have long studied bacteria in tumors, a new international study reveals that fungi—often overlooked microorganisms—play a crucial role in determining whether kidney cancer patients will respond to immunotherapy.

"We were amazed to find that the fungal communities living inside kidney tumors have such a profound impact on patient survival," said Peng Luo. "This opens up an entirely new avenue for understanding why some patients respond well to treatment while others don't."

The research team analyzed tumor samples from over 1,000 kidney cancer patients across four countries—the largest study of its kind. They discovered that patients whose tumors contained abundant fungal communities had significantly worse outcomes and were less likely to benefit from immunotherapy.

A Hidden Player in Cancer Biology

What makes this finding particularly striking is how the fungi operate. The researchers observed that these tumor-dwelling fungi appear to interfere with the body's natural cancer-fighting mechanisms through two potential pathways: they may disrupt the tumor's ability to break down fats for energy, and could contribute to T cell exhaustion—weakening the very immune cells that immunotherapy drugs are designed to strengthen.

"It's like the fungi are creating a hostile environment that shields the cancer from both the immune system and our treatments," explained Peng Luo. "Understanding this gives us new targets for intervention."

Clinical Applications on the Horizon

The team developed predictive tools based on fungal signatures that can accurately forecast treatment success not only in kidney cancer but potentially in other cancer types. They also identified a specific fungal species, Aspergillus tanneri, as particularly problematic for patient outcomes.

This research shines new light on the complex ecosystem within tumors and suggests that successful cancer treatment may require addressing not just the cancer cells themselves, but the entire microbial community supporting them. The findings could lead to combination therapies that target both the tumor and its fungal inhabitants, potentially improving outcomes for the many patients who currently don't respond to immunotherapy.

"We're essentially rewriting the playbook on how we think about the tumor environment," noted Peng Luo. "The implications extend far beyond kidney cancer."

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.